IRIS
VITALE, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.512
EU - Europa 10.475
AS - Asia 6.202
SA - Sud America 1.178
AF - Africa 376
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 6
Totale 30.767
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.318
GB - Regno Unito 2.699
RU - Federazione Russa 2.038
IT - Italia 1.915
CN - Cina 1.894
SG - Singapore 1.830
IE - Irlanda 994
BR - Brasile 962
VN - Vietnam 816
UA - Ucraina 597
SE - Svezia 544
FR - Francia 503
HK - Hong Kong 486
DE - Germania 450
FI - Finlandia 336
KR - Corea 299
BD - Bangladesh 242
ZA - Sudafrica 194
IN - India 175
NL - Olanda 109
CA - Canada 91
TR - Turchia 86
AR - Argentina 70
PL - Polonia 61
IQ - Iraq 59
MX - Messico 59
JP - Giappone 53
PK - Pakistan 50
ES - Italia 41
EC - Ecuador 35
NG - Nigeria 32
BE - Belgio 30
CZ - Repubblica Ceca 29
ID - Indonesia 29
KE - Kenya 29
MA - Marocco 29
VE - Venezuela 29
SA - Arabia Saudita 25
AT - Austria 24
CI - Costa d'Avorio 24
CO - Colombia 19
DZ - Algeria 19
CL - Cile 18
PE - Perù 18
UZ - Uzbekistan 18
JO - Giordania 16
AE - Emirati Arabi Uniti 15
AU - Australia 15
EG - Egitto 15
CH - Svizzera 14
IR - Iran 14
TN - Tunisia 13
PH - Filippine 12
JM - Giamaica 11
LT - Lituania 11
GR - Grecia 10
NP - Nepal 10
UY - Uruguay 10
BY - Bielorussia 9
LB - Libano 9
PY - Paraguay 9
CR - Costa Rica 8
IL - Israele 8
MY - Malesia 8
AL - Albania 7
DK - Danimarca 7
HU - Ungheria 7
BO - Bolivia 6
KZ - Kazakistan 6
RS - Serbia 6
BH - Bahrain 5
ET - Etiopia 5
EU - Europa 5
OM - Oman 5
PA - Panama 5
PT - Portogallo 5
RO - Romania 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
HN - Honduras 4
NO - Norvegia 4
PS - Palestinian Territory 4
SN - Senegal 4
AO - Angola 3
BG - Bulgaria 3
BW - Botswana 3
CY - Cipro 3
LV - Lettonia 3
NI - Nicaragua 3
TH - Thailandia 3
TW - Taiwan 3
AM - Armenia 2
CG - Congo 2
DO - Repubblica Dominicana 2
GY - Guiana 2
HR - Croazia 2
KG - Kirghizistan 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
Totale 30.738
Salva come PNG Salva come JPEG
Città #
Southend 2.461
Dallas 1.836
Fairfield 1.216
Singapore 1.024
Dublin 979
Ashburn 921
Santa Clara 641
Moscow 568
Woodbridge 567
Jacksonville 479
Seattle 470
Wilmington 470
Hong Kong 465
Chandler 463
Houston 463
San Jose 429
Cambridge 420
Beijing 410
Hefei 409
Siena 354
Ann Arbor 327
Menlo Park 319
Seoul 294
New York 268
Ho Chi Minh City 247
Princeton 234
Milan 222
The Dalles 212
Los Angeles 201
Hanoi 197
Helsinki 195
Johannesburg 181
Lauterbourg 175
Council Bluffs 156
Nanjing 153
Rome 138
Munich 97
San Mateo 87
São Paulo 86
Buffalo 83
San Diego 75
Dong Ket 73
Dearborn 72
Boardman 65
Orem 59
Nanchang 58
Bengaluru 55
Florence 54
Düsseldorf 51
Columbus 48
Chicago 47
Redondo Beach 47
Da Nang 46
Frankfurt am Main 45
Shenyang 45
London 43
Shanghai 42
Warsaw 38
Tokyo 37
Lappeenranta 36
Haiphong 32
Nuremberg 32
Tianjin 32
Abuja 31
Bologna 31
Changsha 31
San Francisco 31
Chennai 29
Guangzhou 29
Brooklyn 28
Izmir 28
Rio de Janeiro 28
Washington 28
Jiaxing 27
Turku 27
Turin 26
Brussels 25
Hebei 25
Mexico City 25
Abidjan 24
Amsterdam 23
Montreal 23
Naples 21
Norwalk 21
Olomouc 21
Portsmouth 21
Denver 20
Jinan 20
Kraków 20
Toronto 20
Baghdad 19
Stockholm 19
Atlanta 18
Belo Horizonte 18
Istanbul 18
Kunming 18
Manchester 18
Bari 17
Campinas 17
Phoenix 17
Totale 20.911
Salva come PNG Salva come JPEG
Nome #
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 888
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 404
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 355
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 348
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 345
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 330
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 314
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 312
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 310
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders 293
A case of resistant adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome responsive to anakinra. 292
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 290
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 282
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 271
Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: a multicenter retrospective observational study 270
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis 269
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 264
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 263
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 262
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 259
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 258
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: An observational multicentre study 257
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 247
Weekly oral alendronate in mevalonate kinase deficiency 240
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 240
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 239
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 237
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 233
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 233
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 231
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 231
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 230
Clinical and biochemical landmarks in systemic autoinflammatory diseases 224
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 223
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 223
Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 221
A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project 219
Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease 218
Childhood versus adulthood-onset autoinflammatory disorders: myths and truths intertwined 217
Immunometabolic biomarkers of inflammation in Behçet's disease: Relationship with epidemiological profile, disease activity and therapeutic regimes 216
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature 215
Development and implementation of the AIDA international registry for patients with non-infectious uveitis 213
Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs) 211
Working the endless puzzle of hereditary autoinflammatory disorders. 211
Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease 208
Anakinra long-term efficacy and safety in the management of Schnitzler's syndrome and latent tuberculosis infection 206
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature 205
Anakinra drug retention rate and predictive factors of long-term response in systemic juvenile idiopathic arthritis and adult onset still disease 203
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 195
Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience 195
Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review 194
Development and implementation of the AIDA International Registry for patients with Behçet's disease 193
Clinical profile and evolution of patients with juvenile-onset Behçet's syndrome over a 25-year period: insights from the AIDA network 191
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease 191
Coexistence of axial spondyloarthritis and thromboangiitis obliterans in a young woman 190
Canakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: real-life experience from the international AIDA registry 188
Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case Series 186
The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study 186
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study 186
The hereditary autoinflammatory disorders uncovered 185
Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives 182
Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study 182
The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: Clinical manifestations and long-term follow-up 180
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 180
Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues 179
Development and implementation of the AIDA international registry for patients with non-infectious scleritis 178
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives 178
Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases 178
Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in refractory Behçet disease uveitis and concomitant bladder papillary carcinoma 177
Autoinflammatory diseases 177
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 177
Ultrasound guided corticosteroids sacroiliac joint injections (SIJIs) in the management of active sacroiliitis: a real-life prospective experience 175
Circulating intercellular adhesion molecule 1 (sICAM-1) in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) 175
Dry eye disease and spondyloarthritis: expanding the spectrum of systemic inflammatory disorders associated with ocular surface disease. Data from the international AIDA Network Spondyloarthritis Registry 172
Diagnosis and classification of relapsing polychondritis 172
Idiopathic inflammatory myopathies: an update on classification and treatment with special focus on juvenile forms 171
Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers 170
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives 168
Serum amyloid-A in Behçet's disease 168
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders 167
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network 167
The role of the F402L allele in the NLRP12-autoinflammatory disorder. Reply to: F402L variant in NLRP12 in subjects with undiagnosed periodic fevers and in healthy controls 166
The most recent advances in pathophysiology and management of tumour necrosis factor receptor-associated periodic syndrome (TRAPS): personal experience and literature review 165
Adalimumab Monotherapy or Combination Therapy With Methotrexate in Paediatric Uveitis: Data From the AIDA Network Uveitis Registry 164
Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis 164
Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection 163
Paradoxical mucocutaneous flare in a case of Behçet's disease treated with tocilizumab 161
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network 159
Successful use of canakinumab in a patient with resistant Behçet's disease 154
Development and Implementation of the AIDA International Registry for Patients With Undifferentiated Systemic AutoInflammatory Diseases 151
null 150
Paraneoplastic arthritides: an up-to-date case-based systematic review 149
Proinflammatory Cytokines and Antiskin Autoantibodies in Patients With Inherited Epidermolysis Bullosa 149
Evolving Frontiers in the Treatment of Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA) Syndrome 149
Ocular Manifestations in Juvenile Behçet’s Disease: A Registry-Based Analysis from the AIDA Network 148
Comparing biologic options for the management of Behcet's disease-related uveitis 148
Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations 147
Expanding spectrum of TNFRSF1A gene mutations among patients with idiopathic recurrent acute pericarditis 146
Diagnostic role of minor salivary glands biopsy in Sjögren’s syndrome: correlations between histology and autoimmunity in a large, monocentric cohort 145
Development and implementation of the AIDA International Registry for patients with Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis syndrome 143
Totale 21.804
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.775
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.775
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021257 0 0 0 0 0 0 0 0 0 0 0 257
2021/20221.922 183 234 119 134 99 36 82 65 142 232 205 391
2022/20231.806 117 151 245 221 168 342 54 140 210 24 78 56
2023/20241.957 78 47 174 109 96 519 550 82 17 68 65 152
2024/20254.862 263 222 530 271 579 301 219 271 340 233 461 1.172
2025/202611.525 850 1.703 1.512 1.399 1.905 479 1.343 434 403 645 488 364
Totale 31.377